These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24279491)

  • 21. Development of a hollow mesoporous silica nanoparticles vaccine to protect against house dust mite induced allergic inflammation.
    Peng X; Liang Y; Yin Y; Liao H; Li L
    Int J Pharm; 2018 Oct; 549(1-2):115-123. PubMed ID: 30040973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymeric Prodrug Grafted Hollow Mesoporous Silica Nanoparticles Encapsulating Near-Infrared Absorbing Dye for Potent Combined Photothermal-Chemotherapy.
    Zhang Y; Ang CY; Li M; Tan SY; Qu Q; Zhao Y
    ACS Appl Mater Interfaces; 2016 Mar; 8(11):6869-79. PubMed ID: 26937591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracellular redox-activated anticancer drug delivery by functionalized hollow mesoporous silica nanoreservoirs with tumor specificity.
    Luo Z; Hu Y; Cai K; Ding X; Zhang Q; Li M; Ma X; Zhang B; Zeng Y; Li P; Li J; Liu J; Zhao Y
    Biomaterials; 2014 Sep; 35(27):7951-62. PubMed ID: 24930850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Facile synthesis of monodisperse of hollow mesoporous SiO2 nanoparticles and in-situ growth of Ag nanoparticles for antibacterial.
    Xu P; Liang J; Cao X; Tang J; Gao J; Wang L; Shao W; Gao Q; Teng Z
    J Colloid Interface Sci; 2016 Jul; 474():114-8. PubMed ID: 27115332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overcoming acquired drug resistance in colorectal cancer cells by targeted delivery of 5-FU with EGF grafted hollow mesoporous silica nanoparticles.
    Chen L; She X; Wang T; He L; Shigdar S; Duan W; Kong L
    Nanoscale; 2015 Sep; 7(33):14080-92. PubMed ID: 26242620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hierarchically mesoporous silica nanoparticles: extraction, amino-functionalization, and their multipurpose potentials.
    Du X; He J
    Langmuir; 2011 Mar; 27(6):2972-9. PubMed ID: 21332153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hollow mesoporous silica nanoparticles facilitated drug delivery via cascade pH stimuli in tumor microenvironment for tumor therapy.
    Liu J; Luo Z; Zhang J; Luo T; Zhou J; Zhao X; Cai K
    Biomaterials; 2016 Mar; 83():51-65. PubMed ID: 26773665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrasonic Preparation of Nano-CaCO
    Liu X; Wu Z; Cavalli R; Manzoli M; Cravotto G
    AAPS PharmSciTech; 2024 Jul; 25(6):165. PubMed ID: 39009915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intra-articular delivery of celastrol by hollow mesoporous silica nanoparticles for pH-sensitive anti-inflammatory therapy against knee osteoarthritis.
    Jin T; Wu D; Liu XM; Xu JT; Ma BJ; Ji Y; Jin YY; Wu SY; Wu T; Ma K
    J Nanobiotechnology; 2020 Jul; 18(1):94. PubMed ID: 32641147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
    Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
    Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
    [No Abstract]   [Full Text] [Related]  

  • 31. Shortwave Infrared Imaging with J-Aggregates Stabilized in Hollow Mesoporous Silica Nanoparticles.
    Chen W; Cheng CA; Cosco ED; Ramakrishnan S; Lingg JGP; Bruns OT; Zink JI; Sletten EM
    J Am Chem Soc; 2019 Aug; 141(32):12475-12480. PubMed ID: 31353894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro release and in vitro-in vivo correlation for silybin meglumine incorporated into hollow-type mesoporous silica nanoparticles.
    Cao X; Deng WW; Fu M; Wang L; Tong SS; Wei YW; Xu Y; Su WY; Xu XM; Yu JN
    Int J Nanomedicine; 2012; 7():753-62. PubMed ID: 22393284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyaluronic Acid-Functionalized Hollow Mesoporous Silica Nanoparticles as pH-Sensitive Nanocarriers for Cancer Chemo-Photodynamic Therapy.
    Zhou Y; Chang C; Liu Z; Zhao Q; Xu Q; Li C; Chen Y; Zhang Y; Lu B
    Langmuir; 2021 Mar; 37(8):2619-2628. PubMed ID: 33586432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functionalized mesoporous silica nanoparticles and biomedical applications.
    Hoang Thi TT; Cao VD; Nguyen TNQ; Hoang DT; Ngo VC; Nguyen DH
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():631-656. PubMed ID: 30889738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
    Lee JE; Lee N; Kim T; Kim J; Hyeon T
    Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of hollow mesoporous silica nanoparticles with tunable shell thickness and pore size using amphiphilic block copolymers as core templates.
    Zhou X; Cheng X; Feng W; Qiu K; Chen L; Nie W; Yin Z; Mo X; Wang H; He C
    Dalton Trans; 2014 Aug; 43(31):11834-42. PubMed ID: 24957865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
    Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
    Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Albumin-MnO
    Fang J; Wang Q; Yang G; Xiao X; Li L; Yu T
    Colloids Surf B Biointerfaces; 2019 Jul; 179():250-259. PubMed ID: 30978612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silica-based nanoprobes for biomedical imaging and theranostic applications.
    Vivero-Escoto JL; Huxford-Phillips RC; Lin W
    Chem Soc Rev; 2012 Apr; 41(7):2673-85. PubMed ID: 22234515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amino Acid-functionalized hollow mesoporous silica nanospheres as efficient biocompatible drug carriers for anticancer applications.
    Ezzati N; Mahjoub AR; Abolhosseini Shahrnoy A; Syrgiannis Z
    Int J Pharm; 2019 Dec; 572():118709. PubMed ID: 31629730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.